• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泊洛沙姆抑制 CYP3A4、2C9 和 2E1 的活性。

Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1 .

机构信息

Department of Pharmacy, People's Hospital of Rizhao, Rizhao, China.

Department of Pediatrics, People's Hospital of Rizhao, Rizhao, China.

出版信息

Pharm Biol. 2021 Dec;59(1):532-536. doi: 10.1080/13880209.2021.1917630.

DOI:10.1080/13880209.2021.1917630
PMID:33915070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8871619/
Abstract

CONTEXT

Pogostone possesses various pharmacological activities, which makes it widely used in the clinic. Its effect on the activity of cytochrome P450 enzymes (CYP450s) could guide its clinical combination.

OBJECTIVE

To investigate the effect of pogostone on the activity of human CYP450s.

MATERIALS AND METHODS

The effect of pogostone on the activity of CYP450s was evaluated in human liver microsomes (HLMs) compared with blank HLMs (negative control) and specific inhibitors (positive control). The corresponding parameters were obtained with 0-100 μM pogostone and various concentrations of substrates.

RESULTS

Pogostone was found to inhibit the activity of CYP3A4, 2C9, and 2E1 with the IC values of 11.41, 12.11, and 14.90 μM, respectively. The inhibition of CYP3A4 by pogostone was revealed to be performed in a non-competitive and time-dependent manner with the value of 5.69 μM and the KI/K value of 5.86/0.056/(μM/min). For the inhibition of CYP2C9 and 2E1, pogostone acted as a competitive inhibitor with the value of 6.46 and 7.67 μM and was not affected by the incubation time.

DISCUSSION AND CONCLUSIONS

The inhibitory effect of pogostone on the activity of CYP3A4, 2C9, and 2E1 has been disclosed in this study, implying the potential risk during the co-administration of pogostone and drugs metabolized by these CYP450s. The study design provides a reference for further investigations to validate the potential interaction.

摘要

背景

莪术酮具有多种药理活性,因此在临床上得到广泛应用。其对细胞色素 P450 酶(CYP450s)活性的影响可指导其临床联合用药。

目的

研究莪术酮对人细胞色素 CYP450s 活性的影响。

材料与方法

用人肝微粒体(HLMs)与空白 HLMs(阴性对照)和特异性抑制剂(阳性对照)比较,评价莪术酮对 CYP450s 活性的影响。用 0-100 μM 莪术酮和不同浓度的底物获得相应的参数。

结果

莪术酮被发现能抑制 CYP3A4、2C9 和 2E1 的活性,IC 值分别为 11.41、12.11 和 14.90 μM。莪术酮对 CYP3A4 的抑制呈非竞争和时间依赖性,值为 5.69 μM,KI/K 值为 5.86/0.056/(μM/min)。对于 CYP2C9 和 2E1 的抑制,莪术酮为竞争性抑制剂,值为 6.46 和 7.67 μM,不受孵育时间的影响。

讨论与结论

本研究揭示了莪术酮对 CYP3A4、2C9 和 2E1 活性的抑制作用,提示在莪术酮与这些 CYP450 代谢的药物联合使用时存在潜在风险。该研究设计为进一步验证潜在相互作用的研究提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae52/8871619/a1391b816664/IPHB_A_1917630_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae52/8871619/c3a9edaabd5d/IPHB_A_1917630_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae52/8871619/d4a860f27059/IPHB_A_1917630_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae52/8871619/a1391b816664/IPHB_A_1917630_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae52/8871619/c3a9edaabd5d/IPHB_A_1917630_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae52/8871619/d4a860f27059/IPHB_A_1917630_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae52/8871619/a1391b816664/IPHB_A_1917630_F0003_B.jpg

相似文献

1
Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1 .泊洛沙姆抑制 CYP3A4、2C9 和 2E1 的活性。
Pharm Biol. 2021 Dec;59(1):532-536. doi: 10.1080/13880209.2021.1917630.
2
In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes.二氢杨梅素对人肝脏细胞色素P450酶的体外抑制作用。
Pharm Biol. 2017 Dec;55(1):1868-1874. doi: 10.1080/13880209.2017.1339284.
3
Alpinetin suppresses CYP3A4, 2C9, and 2E1 activity .白杨素抑制 CYP3A4、2C9 和 2E1 的活性。
Pharm Biol. 2022 Dec;60(1):1032-1037. doi: 10.1080/13880209.2022.2071450.
4
Rehmannioside A inhibits the activity of CYP3A4, 2C9 and 2D6 in vitro.红景天苷 A 体外抑制 CYP3A4、2C9 和 2D6 的活性。
Xenobiotica. 2024 Apr;54(4):195-200. doi: 10.1080/00498254.2024.2321969. Epub 2024 Mar 4.
5
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes.琥珀酸抑制细胞色素 P450(CYP450)酶的活性。
Pharm Biol. 2020 Dec;58(1):1150-1155. doi: 10.1080/13880209.2020.1839110.
6
Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.阿帕替尼主要代谢物对人及大鼠肝微粒体 CYP450 同工酶的抑制作用。
Toxicol In Vitro. 2024 Mar;95:105739. doi: 10.1016/j.tiv.2023.105739. Epub 2023 Dec 1.
7
Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.安纳皂素 BII 抑制人肝微粒体中 CYP3A4、2D6 和 2E1 的活性。
Pharm Biol. 2020 Dec;58(1):1064-1069. doi: 10.1080/13880209.2020.1835996.
8
inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes.山柰素对人肝细胞色素 P450 酶的抑制作用。
Pharm Biol. 2019 Dec;57(1):571-576. doi: 10.1080/13880209.2019.1656257.
9
In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.大豆苷元对人细胞色素P450 1A2、2C9、3A4/5、2D6和2E1的体外抑制作用
Planta Med. 2017 May;83(8):727-736. doi: 10.1055/s-0042-124615. Epub 2017 Jan 10.
10
effect of pachymic acid on the activity of Cytochrome P450 enzymes.茯苓酸对细胞色素P450酶活性的影响。
Xenobiotica. 2020 Aug;50(8):913-918. doi: 10.1080/00498254.2020.1727062. Epub 2020 Feb 12.

引用本文的文献

1
Unlocking the Therapeutic Potential of Patchouli Leaves: A Comprehensive Review of Phytochemical and Pharmacological Insights.解锁广藿香叶的治疗潜力:植物化学与药理学见解的全面综述
Plants (Basel). 2025 Mar 26;14(7):1034. doi: 10.3390/plants14071034.
2
Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.抗新冠病毒药物与中药之间潜在的药草-药物相互作用。
Acta Pharm Sin B. 2023 Jun 5;13(9):3598-637. doi: 10.1016/j.apsb.2023.06.001.

本文引用的文献

1
The quasi-irreversible inactivation of cytochrome P450 enzymes by paroxetine: a computational approach.帕罗西汀致细胞色素 P450 酶的准不可逆性失活:一种计算方法。
Org Biomol Chem. 2020 May 6;18(17):3334-3345. doi: 10.1039/d0ob00529k.
2
inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes.蛇床子素对人肝细胞色素 P450 酶的抑制作用。
Pharm Biol. 2020 Dec;58(1):247-252. doi: 10.1080/13880209.2020.1741650.
3
[Research progress in molecular pharmacognosy of Pogostemon cablin].广藿香分子生药学研究进展
Zhongguo Zhong Yao Za Zhi. 2019 Nov;44(22):4781-4785. doi: 10.19540/j.cnki.cjcmm.20190729.105.
4
Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism.阿托伐他汀对大鼠氨氯地平药代动力学的影响及其潜在机制。
Xenobiotica. 2020 Jun;50(6):685-688. doi: 10.1080/00498254.2019.1673918. Epub 2019 Oct 9.
5
Pogostone attenuates TNF-α-induced injury in A549 cells via inhibiting NF-κB and activating Nrf2 pathways.莪术醇通过抑制 NF-κB 并激活 Nrf2 通路减轻 TNF-α 诱导的 A549 细胞损伤。
Int Immunopharmacol. 2018 Sep;62:15-22. doi: 10.1016/j.intimp.2018.06.029. Epub 2018 Jun 30.
6
Effects of glycyrrhizin on the pharmacokinetics of asiatic acid in rats and its potential mechanism.甘草酸对大鼠体内齐墩果酸药代动力学的影响及其潜在机制。
Pharm Biol. 2018 Dec;56(1):119-123. doi: 10.1080/13880209.2018.1428634.
7
In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes.二氢杨梅素对人肝脏细胞色素P450酶的体外抑制作用。
Pharm Biol. 2017 Dec;55(1):1868-1874. doi: 10.1080/13880209.2017.1339284.
8
The influence of CYP3A5*3 and BCRPC421A genetic polymorphisms on the pharmacokinetics of felodipine in healthy Chinese volunteers.CYP3A5*3和BCRPC421A基因多态性对非洛地平在健康中国志愿者体内药代动力学的影响。
J Clin Pharm Ther. 2017 Jun;42(3):345-349. doi: 10.1111/jcpt.12505. Epub 2017 Feb 28.
9
Pogostone induces autophagy and apoptosis involving PI3K/Akt/mTOR axis in human colorectal carcinoma HCT116 cells.波戈斯通通过 PI3K/Akt/mTOR 轴诱导人结直肠癌细胞 HCT116 的自噬和凋亡。
J Ethnopharmacol. 2017 Apr 18;202:20-27. doi: 10.1016/j.jep.2016.07.028. Epub 2016 Jul 11.
10
Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism.小檗碱对大鼠氯沙坦及其代谢产物EXP3174药代动力学的影响及其机制。
Pharm Biol. 2016 Dec;54(12):2886-2894. doi: 10.1080/13880209.2016.1190762. Epub 2016 Jun 21.